https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-24 / Intervirology 2012;55(4):276-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-24 / Intervirology 2012;55(4):276-862011-08-24 00:00:002019-02-15 09:21:38Apoptin enhances the oncolytic properties of Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-16 / J. Mol. Med. 2011 Dec;89(12):1231-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-16 / J. Mol. Med. 2011 Dec;89(12):1231-402011-08-16 00:00:002019-02-15 08:50:07HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-08 / J. Clin. Oncol. 2011 Sep;29(27):3677-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-08 / J. Clin. Oncol. 2011 Sep;29(27):3677-852011-08-08 00:00:002019-02-15 08:52:48Immunotherapy for prostate cancer: biology and therapeutic approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-07 / J. Huazhong Univ. Sci. Technol. Med. Sci. 2011 Aug;31(4):488
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-07 / J. Huazhong Univ. Sci. Technol. Med. Sci. 2011 Aug;31(4):4882011-08-07 00:00:002011-08-07 00:00:00Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-04 / Ger Med Sci 2011;9:Doc18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-04 / Ger Med Sci 2011;9:Doc182011-08-04 00:00:002019-02-15 08:45:26Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-01 / Immunol. Res. 2011 Aug;50(2-3):235-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-01 / Immunol. Res. 2011 Aug;50(2-3):235-472011-08-01 00:00:002019-02-15 08:40:04Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-07-31 / J Clin Oncol 29: 2011 (suppl 7; abstr 176)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-07-31 / J Clin Oncol 29: 2011 (suppl 7; abstr 176)2011-07-31 11:54:532019-09-30 09:54:03Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-07-23 / Vaccine 2011 Sep;29(38):6454-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-07-23 / Vaccine 2011 Sep;29(38):6454-632011-07-23 00:00:002019-02-15 08:47:56Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-582011-07-22 00:00:002019-02-15 08:46:38Treatment of high-grade glioma in children and adolescents
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-07-20 / Br J Haematol 2011 Aug;154(4):448-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-07-20 / Br J Haematol 2011 Aug;154(4):448-562011-07-20 00:00:002011-07-20 00:00:00Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies
